In addition, measurement of PTX3 in combination with cytokine levels (IL-6 and IL-18), and other routine clinical parameters rapidly available in ED (e.g., age, urea), can provide a promising approach for 90-days mortality prediction for sepsis patients, better than the use of a single biomarker. This evidence concerns the gene IL18 and Sepsis.